User:Mr. Ibrahem/Copper (64Cu) oxodotreotide

Copper (64Cu) oxodotreotide, sold under the brand name Detectnet, is a radioactive diagnostic agent used in positron emission tomography (PET) of neuroendocrine tumors (NETs). Specifically it is used in adults with somatostatin receptor positive disease. It is given by injection into a vein.

Common side effects include nausea, vomiting, and flushing. Other side effects include radiation exposure and allergic reactions. It interacts with somatostatin analogs. Use during pregnancy may harm the baby. It works by binding to somatostatin receptor, particularly subtype 2 receptors.

Copper (64Cu) oxodotreotide was approved for medical use in the United States in 2020. In the United States it costs about 3,900 USD for a vial as of 2022.